Items where Author is "Wouters, Olivier J."

Wouters, Olivier J. ORCID: 0000-0002-2514-476X (2024) Lobbying in US health care: lessons from the field of oncology. JNCCN. (In Press)

Wouters, Olivier J. ORCID: 0000-0002-2514-476X, Naci, Huseyin and Papanicolas, Irene ORCID: 0000-0002-8000-3185 (2024) Availability and coverage of new drugs in 6 high-income countries with health technology assessment bodies. Journal of American Medical Association: Internal Medicine, 184 (3). 328 - 330. ISSN 2168-6106

Hernandez, Inmaculada, Cousin, Emma, Wouters, Olivier J. ORCID: 0000-0002-2514-476X, Gabriel, Nico, Cameron, Teresa and Sullivan, Sean D. (2024) Medicare drug price negotiation: the complexities of selecting therapeutic alternatives for estimating comparative effectiveness. Journal of Managed Care & Specialty Pharmacy, 30 (3). 218 - 225. ISSN 2376-1032

Vokinger, Kerstin N., Perényi, Gellért and Wouters, Olivier J. ORCID: 0000-0002-2514-476X (2023) Investments in research and development for supplemental drug indications: implications for drug price negotiations. JAMA Health Forum, 4 (9). E232798. ISSN 2689-0186

Wouters, Olivier J. ORCID: 0000-0002-2514-476X, Forman, Rebecca ORCID: 0000-0002-0124-9997, Anderson, Michael ORCID: 0000-0002-8454-4640, Mossialos, Elias ORCID: 0000-0001-8664-9297 and McKee, Martin (2023) The launch of the EU Health Emergency Preparedness and Response Authority (HERA): improving global pandemic preparedness? Health Policy, 133. ISSN 0168-8510

van Kessel, Robin, Forman, Rebecca ORCID: 0000-0002-0124-9997, Milstein, Ricarda, Mastylak, Alicja, Czabanowska, Katarzyna, Czypionka, Thomas, Durand-Zaleski, Isabelle, Hirche, Anja, Krysinska-Pisarek, Magdalena, Roberts, Bjelle, Maynou-Pujolras, Laia ORCID: 0000-0002-0447-2959, Torbica, Aleksandra, Wang, Yuxi, Vrangbæk, Karsten, Wouters, Olivier J. ORCID: 0000-0002-2514-476X and Mossialos, Elias ORCID: 0000-0001-8664-9297 (2023) Divergent COVID-19 vaccine policies: policy mapping of ten European countries. Vaccine, 41 (17). 2804 - 2810. ISSN 0264-410X

Anderson, Michael ORCID: 0000-0002-8454-4640, Wouters, Olivier J. ORCID: 0000-0002-2514-476X and Mossialos, Elias ORCID: 0000-0001-8664-9297 (2023) Transferable exclusivity extensions to stimulate antibiotic research and development: what is at stake? The Lancet Microbe, 4 (3). e127-e128. ISSN 2666-5247

Angelis, Aris ORCID: 0000-0002-0261-4634, Polyakov, Roman, Wouters, Olivier J. ORCID: 0000-0002-2514-476X, Torreele, Els and McKee, Martin (2023) High drug prices are not justified by industry’s spending on research and development. BMJ, 380 (8371). ISSN 1756-1833

Feldman, William B., Tu, S. Sean, Alhiary, Rasha, Kesselheim, Aaron S. and Wouters, Olivier J. ORCID: 0000-0002-2514-476X (2023) Manufacturer revenue on inhalers after expiration of primary patents, 2000-2021. JAMA, 329 (1). 87 - 89. ISSN 0098-7484

Wouters, Olivier J. ORCID: 0000-0002-2514-476X, Feldman, William B. and Tu, S. Sean (2022) Product hopping in the drug industry — lessons from Albuterol. New England Journal of Medicine, 387 (13). 1153 - 1156. ISSN 0028-4793

Wouters, Olivier J. ORCID: 0000-0002-2514-476X, Berenbrok, Lucas A., He, Meiqi, Li, Yihan and Hernandez, Inmaculada (2022) Association of research and development investments with treatment costs for new drugs approved from 2009 to 2018. JAMA network open, 5 (9). ISSN 2574-3805

Wouters, Olivier J. ORCID: 0000-0002-2514-476X, McKee, Martin and Luyten, Jeroen (2022) Errors in source data for study of drug development costs. JAMA, 328 (11). p. 1110. ISSN 0098-7484

McKee, Martin and Wouters, Olivier J. ORCID: 0000-0002-2514-476X (2022) The challenges of regulating artificial intelligence in healthcare: comment on “Clinical decision support and new regulatory frameworks for medical devices: are we ready for it? - a viewpoint paper”. International Journal of Health Policy and Management, 12 (1). pp. 1-4. ISSN 2322-5939

Jit, Mark, Ananthakrishnan, Aparna, McKee, Martin, Wouters, Olivier J. ORCID: 0000-0002-2514-476X, Beutels, Philippe and Teerawattananon, Yot (2021) Multi-country collaboration in responding to global infectious disease threats: lessons for Europe from the COVID-19 pandemic. The Lancet Regional Health - Europe, 9. ISSN 2666-7762

Wouters, Olivier J. ORCID: 0000-0002-2514-476X, Shadlen, Kenneth C ORCID: 0000-0003-4010-4835, Salcher-konrad, Maximilian ORCID: 0000-0002-5628-5266, Pollard, Andrew J, Larson, Heidi J, Teerawattananon, Yot and Jit, Mark (2021) Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. The Lancet, 397 (10278). 1023 - 1034. ISSN 0140-6736

Wouters, Olivier J. ORCID: 0000-0002-2514-476X (2021) Vaccine nationalism risks prolonging the global pandemic. LSE COVID-19 Blog (24 Feb 2021). Blog Entry.

Shi, Wunan, Wouters, Olivier J. ORCID: 0000-0002-2514-476X, Liu, Gordon, Mossialos, Elias ORCID: 0000-0001-8664-9297 and Yang, Xiuyun (2020) Association between provincial income levels and drug prices in China over the period 2010–2017. Social Science & Medicine, 263. ISSN 0277-9536

Luyten, Jeroen, McKee, Martin and Wouters, Olivier J. ORCID: 0000-0002-2514-476X (2020) Wat kost onderzoek en ontwikkeling van een medicijn? Een oproep tot meer transparantie. Nederlands Tijdschrift voor Geneeskunde, 164 (34). ISSN 0028-2162

Wouters, Olivier J. ORCID: 0000-0002-2514-476X, McKee, Martin and Luyten, Jeroen (2020) Research and development costs of new drugs: in reply. JAMA, 324 (5). p. 518. ISSN 0098-7484

van Schalkwyk, May C.I., Jarman, Holly, Hervey, Tamara, Wouters, Olivier J. ORCID: 0000-0002-2514-476X, Barlow, Pepita and McKee, Martin (2020) Risks to health and the NHS in the post-Brexit era. BMJ (Clinical research ed.), 369. ISSN 1756-1833

Wouters, Olivier J. ORCID: 0000-0002-2514-476X (2020) Lobbying expenditures and campaign contributions by the pharmaceutical and health-product industry in the United States, 1999- 2018. Journal of American Medical Association: Internal Medicine, 180 (5). 688 - 697. ISSN 2168-6106

Wouters, Olivier J. ORCID: 0000-0002-2514-476X, Hervey, Tamara and McKee, Martin (2020) Brexit and the European Medicines Agency—what next for the Agency and UK drug regulators? JAMA Health Forum (18 Feb 2020). Blog Entry.

Wouters, Olivier J. ORCID: 0000-0002-2514-476X, McKee, Martin and Luyten, Jeroen (2020) Estimated research and development investment needed to bring a new medicine to market, 2009-2018. JAMA, 323 (9). 844 - 853. ISSN 0098-7484

Wouters, Olivier J. ORCID: 0000-0002-2514-476X (2018) Essays on prices, volumes and policies in generic drug markets in high- and middle-income countries. Doctoral thesis, Social Policy.

Wouters, Olivier J. ORCID: 0000-0002-2514-476X, Sandberg, Dale M., Pillay, Anban and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2018) The impact of pharmaceutical tendering on prices and market concentration in South Africa over a 14-year period. Social Science & Medicine. ISSN 0277-9536

Wouters, Olivier J. ORCID: 0000-0002-2514-476X, Kanavos, Panos ORCID: 0000-0001-9518-3089 and McKee, Martin (2017) Comparing generic drug markets in Europe and the United States: prices, volumes, and spending. The Milbank Quarterly, 95 (3). 554 - 601. ISSN 0887-378X

Naci, Huseyin, Wouters, Olivier J. ORCID: 0000-0002-2514-476X, Gupta, Radhika and Ioannidis, John P. A. (2017) Timing and characteristics of cumulative evidence available on novel therapeutic agents receiving Food and Drug Administration accelerated approval. The Milbank Quarterly, 95 (2). 261 - 290. ISSN 0887-378X

Wouters, Olivier J. ORCID: 0000-0002-2514-476X and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2017) A comparison of generic drug prices in seven European countries: a methodological analysis. BMC Health Services Research, 17 (242). pp. 1-7. ISSN 1472-6963

Kanavos, Panos ORCID: 0000-0001-9518-3089 and Wouters, Olivier J. ORCID: 0000-0002-2514-476X (2017) Health care after the Great Recession: financing options for sustainable and high-quality health systems. Global Policy, 8 (S2). pp. 5-6. ISSN 1758-5880

Wouters, Olivier J. ORCID: 0000-0002-2514-476X and McKee, Martin (2017) Private financing of health care in times of economic crisis: a review of the evidence. Global Policy, 8 (S2). pp. 23-29. ISSN 1758-5880

Laviolette, Luc, Gopalan, Sudararajan, Elder, Leslie and Wouters, Olivier J. ORCID: 0000-0002-2514-476X (2016) Incentivizing nutrition: how to apply incentive mechanisms to accelerate improved nutrition outcomes: a practitioner’s compendium. . World Bank, Washington D.C., USA.

Laviolette, Luc, Gopalan, Sudararajan, Elder, Leslie and Wouters, Olivier J. ORCID: 0000-0002-2514-476X (2016) Incentivizing nutrition: incentive mechanisms to accelerate improved nutrition outcomes. . World Bank, Washington D.C., USA.

Wouters, Olivier J. ORCID: 0000-0002-2514-476X, Cylus, Jonathan ORCID: 0000-0001-8269-1578, Yang, Wei, Thomson, Sarah and McKee, Martin (2016) Medical savings accounts: assessing their impact on efficiency, equity, and financial protection in health care. Health Economics, Policy and Law, 11 (3). pp. 321-335. ISSN 1744-1331

Panteli, Dimitra, Arickx, Francis, Cleemput, Irina, Dedet, Guillaume, Eckhardt, Helene, Fogarty, Emer, Gerkens, Sophie, Henschke, Cornelia, Hislop, Jennifer, Jommi, Claudio, Kaitelidou, Daphne, Kawalec, Pawel, Keskimäki, Ilmo, Kroneman, Madelon, Lopez Bastida, Julio, Pita Barros, Pedro, Ramsberg, Joakim, Schneider, Peter, Spillane, Susan, Vogler, Sabine, Vuorenkoski, Lauri, Wallach Kildemoes, Helle, Wouters, Olivier J. ORCID: 0000-0002-2514-476X and Busse, Reinhard (2016) Pharmaceutical regulation in 15 European countries: review. Health Systems in Transition, 18 (5). pp. 1-118. ISSN 1817-6119

Wouters, Olivier J. ORCID: 0000-0002-2514-476X, Naci, Huseyin and Samani, Nilesh J (2015) QALYs in cost-effectiveness analysis: an overview for cardiologists. Heart, 10 (23). pp. 1868-1873. ISSN 1355-6037

Cylus, Jonathan ORCID: 0000-0001-8269-1578, Wouters, Olivier J. ORCID: 0000-0002-2514-476X and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2015) Understanding the role of governance in the pharmaceutical sector: from laboratory to patient. In: Greer, Scott, Wismar, Matthias and Figueras, Josep, (eds.) Strengthening Health System Governance: Better Policies, Stronger Performance. Open University, Maidenhead, UK, pp. 175-187. ISBN 9780335261345

Wouters, Olivier J. ORCID: 0000-0002-2514-476X and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2015) Primary health care should play bigger role in treating chronic kidney disease. Health and Social Care at LSE (18 Oct 2015). Website.

Wouters, Olivier J. ORCID: 0000-0002-2514-476X, O'Donoghue, Donal J., Ritchie, James, Kanavos, Panos ORCID: 0000-0001-9518-3089 and Narva, Andrew S. (2015) Early chronic kidney disease: diagnosis, management and models of care. Nature Reviews Nephrology, 11 (8). pp. 491-502. ISSN 1759-5061

Naci, Huseyin, Lehman, Richard, Wouters, Olivier J. ORCID: 0000-0002-2514-476X, Goldacre, Ben and Yudkin, John S (2015) Rethinking the appraisal and approval of drugs for type 2 diabetes. BMJ, 351 (h5260). ISSN 1756-1833

Wouters, Olivier J. ORCID: 0000-0002-2514-476X and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2015) Transitioning to a national health system in Cyprus: a stakeholder analysis of pharmaceutical policy reform. Bulletin of the World Health Organization, 93 (9). pp. 606-613. ISSN 0042-9686

Chambers, James D., Naci, Huseyin, Wouters, Olivier J. ORCID: 0000-0002-2514-476X, Pyo, Junhee, Gunjal, Shalak, Kennedy, Ian R., Hoey, Mark G., Winn, Aaron and Neumann, Peter J. (2015) An assessment of the methodological quality of published network meta-analyses: a systematic review. PLOS ONE, 10 (4). ISSN 1932-6203

Kanavos, Panos ORCID: 0000-0001-9518-3089 and Wouters, Olivier J. ORCID: 0000-0002-2514-476X (2014) Pharmaceutical policies in Cyprus: a review of the current system and future options. . World Health Organization, Copenhagen, Denmark.

Kanavos, Panos ORCID: 0000-0001-9518-3089 and Wouters, Olivier J. ORCID: 0000-0002-2514-476X (2014) Pharmaceutical parallel trade: legal, policy, and economic issues. In: Culyer, Anthony J., (ed.) Encyclopedia of health economics. Elsevier (Firm), San Diego, USA, pp. 20-28. ISBN 9780123756787

Wouters, Olivier J. ORCID: 0000-0002-2514-476X, Downs, Philip W., Zoerhoff, Kathryn L., Crowley, Kathryn R., Frawley, Hannah, Einberg, Jennifer, Chu, Brian K., Brady, Molly A., Oscar, Roland, Jeudi, Mireille, Desormeaux, Anne-Marie, Coly, Karleen, Direny, Abdel N., Thakur, Garib D., Pokharel, Raj K., Sharma, Shekhar, Raman, Dharmpal P., Sesay, Santigie, Sonnie, Mustapha, Kilembe, Bernard, Mwingira, Upendo and Yajima, Aya (2014) Resource planning for Neglected Tropical Disease (NTD) Control Programs: feasibility study of the Tool for Integrated Planning and Costing (TIPAC). PLoS Neglected Tropical Diseases, 8 (2). e2619. ISSN 1935-2735

Kanavos, Panos ORCID: 0000-0001-9518-3089 and Wouters, Olivier J. ORCID: 0000-0002-2514-476X (2014) Concurrence dans la distribution de produits pharmaceutiques. In: OECD Forum Mondial sur la Concurrence, 2014-02-27 - 2014-02-28, Paris, France.

Kanavos, Panos ORCID: 0000-0001-9518-3089 and Wouters, Olivier J. ORCID: 0000-0002-2514-476X (2014) Competition issues in the distribution of pharmaceuticals. In: OECD Global Forum on Competition, 2014-02-27 - 2014-02-28, Paris, France.